NCT07533825 2026-04-16
CGCA202501
Tianjin Medical University Cancer Institute and Hospital
Phase NA Enrolling by invitation
Clinical Trials
8 trialsNCT07218003 2026-03-23
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Phase 1 Enrolling by invitation
NCT07488312 2026-03-23
LUCENT-GC-01
Qilu Hospital of Shandong University
Phase 1 Enrolling by invitation
NCT07444099 2026-03-02
Early Postoperative Intervention in Gastric Cancer Patients
Qilu Hospital of Shandong University
Phase NA Enrolling by invitation
NCT07356466 2026-01-21
FUGES032
Fujian Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023848 2025-06-17
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07023861 2025-06-17
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Enrolling by invitation
NCT06785922 2025-01-21
Differences in Gastric Microbiota in Patients Who Were Infected Between CagA Positive and Negative Helicobacter Pylori
Mahidol University
Phase NA Enrolling by invitation